A recent study revealed that AKR1C3 was upregulated in erastin-resistant DU-145 prostate cancer cells (22), implying that AKR1C3 may be a suppressor of cell ferroptosis. This evidence concerns the gene AKR1C3 and Familial prostate cancer.